Loviselli A, Mathieu A, Pala R, Mariotti S, Cau S, Marongiu C, Mazzoleni AP, Maggio P, Martino E
Dng bo ch tin dng: Bo ch dng vin nang tin li d ung v ng trong l kn m bo cht lng
Experientia 24, 511513
MAPP investigators performed a 1-year observational cohort study of over 200 women with IC/BPS and identified important clinical factors associated with quality-of-life outcomes and with symptom trajectories over time, including the presence of pain outside the pelvis, the presence of concurrent nonurological chronic pain conditions (such as fibromyalgia and irritable bowel syndrome), and the severity of bladder-focused symptoms (
( Previous alkylation studies of GSTA1 focused on in vivo binding of bromobenzene metabolites to Cys112 in rat (Koen et al., In comparison to our findings of NAPQI-modified Cys78 in GSTM1, Nerland et al
Expect results between topical and injectable in terms of magnitude